Stryker Corporation: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:StrykerLogo.png|right|thumb|150px|Stryker logo]] |
[[Image:StrykerLogo.png|right|thumb|150px|Stryker logo]] |
||
'''Stryker Corporation''' {{NYSE|SYK}} is |
'''Stryker Corporation''' {{NYSE|SYK}} is a medical technology company with a broad range of products in orthopaedics and a significant presence in other medical specialties. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. Stryker also provides outpatient physical therapy services in the United States. |
||
==Company History== |
==Company History== |
||
On February 20, 1946 the Orthopedic Frame Company was incorporated by [[Homer Stryker|Dr. Homer Stryker]], an orthopaedic surgeon from [[Kalamazoo, Michigan]], to sell his inventions including the Turning Frame and Walking Heel. In 1964 the company name was changed to Stryker Corporation. In 1978, one year after [[John Brown]] was named President and CEO, annual sales reached $22.7 million. In 1979 Stryker made an initial public offering of stock and later acquired Osteonics Corporation, entering the replacement hip, knee, and other orthopaedic implants market. Annual sales reached $2.1 billion in 1999 and in 2000 Stryker was included in the S&P 500 and the Forbes Platinum 400 for the first time. In 2002 sales reached $3.0 billion and Stryker was listed in the [[Fortune 500]] for the first time. |
|||
In 2003 Steve MacMillan joined Stryker as President and COO. In 2005 annual sales reached $4.9 billion and John W. Brown transitioned to the single role of Chairman of the Board while Stephen P. MacMillan became President & CEO. In 2006 Stryker acquired Sightline and entered the Gastrointestinal market. |
|||
==Corporate Governance== |
|||
Current members of the [[board of directors]] of Stryer Corporation are: |
|||
*John W. Brown, Chairman |
|||
*Stephen P. MacMillan |
|||
*Howard E. Cox, Jr. |
|||
*Donald M. Engelman, Ph.D. |
|||
*Jerome H. Grossman, M.D. |
|||
*William U. Parfet |
|||
*Ronda E. Stryker |
|||
*Louise L. Francesconi |
|||
==External link== |
==External link== |
||
Revision as of 01:19, 25 January 2007
Stryker Corporation NYSE: SYK is a medical technology company with a broad range of products in orthopaedics and a significant presence in other medical specialties. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. Stryker also provides outpatient physical therapy services in the United States.
Company History
On February 20, 1946 the Orthopedic Frame Company was incorporated by Dr. Homer Stryker, an orthopaedic surgeon from Kalamazoo, Michigan, to sell his inventions including the Turning Frame and Walking Heel. In 1964 the company name was changed to Stryker Corporation. In 1978, one year after John Brown was named President and CEO, annual sales reached $22.7 million. In 1979 Stryker made an initial public offering of stock and later acquired Osteonics Corporation, entering the replacement hip, knee, and other orthopaedic implants market. Annual sales reached $2.1 billion in 1999 and in 2000 Stryker was included in the S&P 500 and the Forbes Platinum 400 for the first time. In 2002 sales reached $3.0 billion and Stryker was listed in the Fortune 500 for the first time.
In 2003 Steve MacMillan joined Stryker as President and COO. In 2005 annual sales reached $4.9 billion and John W. Brown transitioned to the single role of Chairman of the Board while Stephen P. MacMillan became President & CEO. In 2006 Stryker acquired Sightline and entered the Gastrointestinal market.
Corporate Governance
Current members of the board of directors of Stryer Corporation are:
- John W. Brown, Chairman
- Stephen P. MacMillan
- Howard E. Cox, Jr.
- Donald M. Engelman, Ph.D.
- Jerome H. Grossman, M.D.
- William U. Parfet
- Ronda E. Stryker
- Louise L. Francesconi
External link
 | This corporation or company article is a stub. You can help Wikipedia by expanding it. |